Friedreich Ataxia Clinical Trials in New Delhi, National Capital Territory of Delhi
2 recruitingNew Delhi, National Capital Territory of Delhi, India
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Learn More About the Effects and Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old (BRAVE)
Friedreich Ataxia
Biogen255 enrolled34 locationsNCT06953583
Recruiting
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Friedreich Ataxia
Friedreich's Ataxia Research Alliance3,000 enrolled34 locationsNCT06016946